|
1
|
Kaminski M and Wiaderkiewicz R: The role
of the liver in xenobiotic biotransformation. Part I. The role of
the liver and its cells and their interactions. Problems of
Forensic Sciences. LXXII:357–378. 2007.
|
|
2
|
Manibusan MK, Odin M and Eastmon DA:
Postulated carbon tetrachloride mode of action: A review. J Environ
Sci Health C Environ Carcinog Ecotoxicol Rev. 25:185–209. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weber LW, Boll M and Stampfl A:
Hepatotoxicity and mechanism of action of haloalkanes: Carbon
tetrachloride as a toxicological model. Crit Rev Toxicol.
33:105–136. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong D, Zhang S, Yin L, Tang X, Xu Y, Han
X, Qi Y and Peng J: Protective effects of the total saponins from
Rosa laevigata Michx fruit against carbon tetrachloride-induced
acute liver injury in mice. Food Chem Toxicol. 62:120–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamel R and El Morsy EM: Hepatoprotective
effect of methylsulfonylmethane against carbon
tetrachloride-induced acute liver injury in rats. Arch Pharm Res.
36:1140–1148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pfeffer K: Biological functions of tumor
necrosis factor cytokines and their receptors. Cytokine Growth
Factor Rev. 14:185–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alric L, Pinelli E, Carrera G, Vinel JP,
Beraud M, Duffaut M, Pascal JP and Pipy B: Involvement of calcium
in macrophage leukotriene release during experimental cirrhosis.
Hepatology. 23:614–622. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tarras N, Moles A, Morales A, García-Ruiz
C, Fernández-Checa JC and Marí M: Critical role of tumor necrosis
factor receptor 1, but not 2, in hepatic stellate cell
proliferation, extracellular matrix remodeling and liver
fibrogenesis. Hepatology. 54:319–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leask A and Abraham D: TGF-beta signaling
and the fibrotic response. FASEB J. 18:816–827. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lobo V, Patil A, Phatak A and Chandra N:
Free radicals, antioxidants and functional foods: Impact on human
health. Pharmacogn Rev. 4:118–126. 2014. View Article : Google Scholar
|
|
12
|
Pietta PG: Flavonoids as Antioxidants. J
Nat Prod. 63:1035–1042. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abascal K and Yarnell E: The many faces of
Silybum marianum (Milk Thistle): Part 2- clinical uses, safety and
types of preparations. Alternative and Complementary Therapies.
9:251–256. 2003. View Article : Google Scholar
|
|
14
|
Kshirsagar A, Ingawale D, Ashok P and
Vyawahare N: Silymarin: A comprehensive review. Phcog Rev.
3:126–134. 2009.
|
|
15
|
Siess MH, Le Bon AM, Canivenc-Lavier MC,
Amiot MJ, Sabatier S, Aubert SY and Suschetet M: Flavonoids of
honey and propolis: Characterization and effects on hepatic drug
metabolizing enzymes and benzo[a]pyrene-DNA binding in rats. J
Agric Food Chem. 44:2297–2301. 1996. View Article : Google Scholar
|
|
16
|
Anand KV, Anandhi R, Pakkiyaraj M and
Geraldine P: Protective effect of chrysin on carbon tetrachloride
(CCl4)-induced tissue injury in male Wistar rats. Toxicol Ind
Health. 27:923–933. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pushpavalli G, Kalaiarasi P, Veeramani C
and Pugalendi KV: Effect of chrysin on hepatoprotective and
antioxidant status in D-galactosamine-induced hepatitis in rats.
Eur J Pharmacol. 631:36–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brechbuhl HM, Kachadourian R, Min E, Chan
D and Day BJ: Chrysin enhances doxorubicin-induced cytotoxicity in
human lung epithelial cancer cell lines: The role of glutathione.
Toxicol Appl Pharmacol. 258:1–9. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bae Y, Lee S and Kim SH: Chrysin
suppresses mast cell-mediated allergic inflammation: Involvement of
calcium, caspase-1 and nuclear factor-κB. Toxicol Appl Pharmacol.
254:56–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin EK, Kwon HS, Kim YH, Shin HK and Kim
JK: Chrysin, a natural flavone, improves murine inflammatory bowel
diseases. Biochem Biophys Res Commun. 381:502–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balta C, Herman H, Boldura OM, Gasca I,
Rosu M, Ardelean A and Hermenean A: Chrysin attenuates liver
fibrosis and hepatic stellate cell activation through TGF-b/Smad
signaling pathway. Chem Biol Interact. 240:94–101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan MS, Devaraj H and Devaraj N: Chrysin
abrogates early hepatocarcinogenesis and induces apoptosis in
N-nitrosodiethylamine-induced preneoplastic nodules in rats.
Toxicol Appl Pharmacol. 251:85–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Phan TA, Yu XM, Kunnimalaiyaan M and Chen
H: Antiproliferative effect of chrysin on anaplastic thyroid
cancer. J Surg Res. 170:84–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khan R, Khan AQ, Qamar W, Lateef A, Tahir
M, Rehman MU, Ali F and Sultana S: Chrysin protects against
cisplatin-induced colon. toxicity via amelioration of oxidative
stress and apoptosis: Probable role of p38MAPK and p53. Toxicol
Appl Pharmacol. 258:315–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niu X, Umland S, Ingram R, Beyer BM, Liu
YH, Sun J, Lundell D and Orth P: IK682, a tight binding inhibitor
of TACE. Arch Biochem Biophys. 451:43–50. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hyperchem, Hypercube, Inc.; USA: 2002
|
|
27
|
Rarey M, Kramer B, Lengauer T and Klebe G:
A fast flexible docking method using an incremental construction
algorithm. J Mol Biol. 261:470–489. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Patel DS and Bharatam PV: New leads for
selective GSK-3 inhibition: Pharmacophore mapping and virtual
screening studies. J Comput Aided Mol Des. 20:55–66. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clawson GA: Mechanisms of carbon
tetrachloride hepatotoxicity. Pathol Immunopathol Res. 8:104–112.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wahlang B, Beier J, Clair H, Bellis-Jones
HJ, Falkner KC, McClain CJ and Cave MC: Toxicant-associated
steatohepatitis. Toxicol Pathol. 41:343–360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brenner C, Galluzzi L, Kepp O and Kroemer
G: Decoding cell death signals in liver inflammation. J Hepatol.
59:583–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Orfila C, Lepert JC, Alric L, Carrera G,
Beraud M, Vinel JP and Pipy B: Expression of TNF-alpha and
immunohistochemical distribution of hepatic macrophage surface
markers in carbon tetrachloride-induced chronic liver injury in
rats. Histochem J. 31:677–685. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ai G, Liu Q, Hua W, Huang Z and Wang D:
Hepatoprotective evaluation of the total flavonoids extracted from
flowers of Abelmoschus manihot (L.) Medic: In vitro and in vivo
studies. J Ethnopharmacol. 146:794–802. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Domitrović R, Jakovac H and Blagojević G:
Hepatoprotective activity of berberine is mediated by inhibition of
TNF-α, COX-2, and iNOS expression in CCl(4)-intoxicated mice.
Toxicology. 280:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim M, Yang SG, Kim JM, Lee JW, Kim YS and
Lee JI: Silymarin suppresses hepatic stellate cell activation in a
dietary rat model of non-alcoholic steatohepatitis: Αnalysis of
isolated hepatic stellate cells. Int J Mol Med. 30:473–479.
2012.PubMed/NCBI
|
|
37
|
Ozturk F, Gul M, Ates B, Ozturk IC, Cetin
A, Vardi N, Otlu A and Yilmaz I: Protective effect of apricot
(Prunus armeniaca L.) on hepatic steatosis and damage induced by
carbon tetrachloride in Wistar rats. Br J Nutr. 102:1767–1775.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tasci I, Mas N, Mas MR, Tuncer M and
Comert B: Ultrastructural changes in hepatocytes after taurine
treatment in CCl4 induced liver injury. World J
Gastroenterol. 14:4897–4902. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheville N: Ultrastructural pathology and
interorgannelle cross talk in hepatotoxicity. Toxicol Pathol.
41:210–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Maskos K, Fernandez-Catalan C, Huber R,
Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch
CT, Castner BJ, et al: Crystal structure of the catalytic domain of
human tumor necrosis factor-αlpha-converting enzyme. Proc Natl Acad
Sci USA. 95:3408–3412. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Grams F, Reinemer P, Powers JC, Kleine T,
Pieper M, Tschesche H, Huber R and Bode W: X-ray structures of
human neutrophil collagenase complexed with peptide hydroxamate and
peptide thiol inhibitors. Implications for substrate binding and
rational drug design. Eur J Biochem. 228:830–841. 1995. View Article : Google Scholar : PubMed/NCBI
|
